ValidCare

uMotif is a modern eCOA/ePRO and eConsent platform designed to power clinical and real-world research. Developed in collaboration with patients, the platform delivers unrivaled engagement, transforming the speed, quality, and accuracy of data. By combining uMotif's eCOA/ePRO with continuous glucose monitoring data capture, the platform delivered unprecedented data compliance rates for a pan-European diabetes study. In an immunology study, the patient-centered eCOA/ePRO solution helped the sponsor complete data capture requirements six months early. In an FDA-required CNS study, participants were engaged to capture submission-ready ePRO through their own devices. uMotif has always designed for patients first, with a relentless focus on understanding the patient journey and what drives patient behavior. This deep knowledge allows the design of software that best meets the needs of patients and delivers exceptionally high levels of engagement to study sponsors.

Science 37 is a clinical research company specializing in decentralized clinical trials through its Metasite model, which eliminates physical proximity as a barrier, enabling patients to participate from anywhere. This approach expands access to over 90% of patients who are unable to participate in traditional site-based research, offering the recruiting power of 20 sites in one and providing the flexibility patients need to participate from anywhere. The Metasite is powered by a proprietary platform that drives uniform study orchestration, guiding the workflow of patients and study staff, and capturing study data without the need for manual reentry. This centralization of people, processes, and platforms delivers built-in protocol compliance, ensuring greater compliance and high-quality data. Science 37's in-house medical teams, telemedicine investigators, and mobile nurses have extensive experience in remote trial conduct across various therapeutic areas, ensuring broad reach.